Insider · CIK 0001635365
Stanley W Peters III
Files at CNMD (CONMED Corp). First filing Nov 9, 2023, latest Jun 17, 2024.
In brief
Stanley W Peters III files SEC Form 4 as president at CNMD (CONMED Corp). Since Nov 9, 2023, Stanley W Peters III has reported 0 open-market buys worth $0 and 3 open-market sells worth $663k, the latest filed on Jun 17, 2024.
A track record needs three past buys with six months of prices behind them; Stanley W Peters III has 0, so none is measured yet.
The newest scored trade: sold $287k of CNMD on Jun 14, 2024, filed Jun 17, 2024, scored 39 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CNMD: CONMED Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | CNMDsell CONMED Corp | $287k 4,000 shares | -98% | +15% from low-47% from high | |
| 38Weak | CNMDsell CONMED Corp | $253k 2,300 shares | -97% | +32% from low-18% from high | |
| 35Weak | CNMDsell CONMED Corp | $123k 1,200 shares | -95% | +37% from low-26% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 27, 2024 | CNMD CONMED Corp | 2,171 0.01% of outstanding | $157k | Aug 27, 2024 | $287k |
| Jun 14, 2024 | CNMD CONMED Corp | 4,000 0.01% of outstanding | $287k | Jun 14, 2024 | none |
| Dec 4, 2023 | CNMD CONMED Corp | 2,300 0.01% of outstanding | $253k | Dec 4, 2023 | $338k |
| Nov 7, 2023 | CNMD CONMED Corp | 1,200 0.00% of outstanding | $123k | Nov 7, 2023 | $215k |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | CNMD CONMED Corp | MOption exercise Common Stock | +4,000 | $41.93 | $168k | 4,063 | Jun 17, 2024 |
| Jun 14, 2024 | CNMD CONMED Corp | SOpen-market sale Common Stock | -4,000 | $71.82 | $287k | 63 | Jun 17, 2024 |
| Jun 14, 2024 | CNMD CONMED Corp | MOption exercise Options To Purchase Common Stockderivative | -4,000 | $0.00 | $0 | 0 | Jun 17, 2024 |
| Mar 1, 2024 | CNMD CONMED Corp | AGrant or award Options To Purchase Common Stockderivative | +33,508 | $0.00 | $0 | 33,508 | Mar 5, 2024 |
| Dec 4, 2023 | CNMD CONMED Corp | MOption exercise Common Stock | +2,300 | $41.93 | $96k | 2,363 | Dec 6, 2023 |
| Dec 4, 2023 | CNMD CONMED Corp | SOpen-market sale Common Stock | -2,300 | $109.93 | $253k | 63 | Dec 6, 2023 |
| Dec 4, 2023 | CNMD CONMED Corp | MOption exercise Options To Purchase Common Stockderivative | -2,300 | $0.00 | $0 | 4,000 | Dec 6, 2023 |
| Nov 7, 2023 | CNMD CONMED Corp | MOption exercise Common Stock | +1,200 | $41.93 | $50k | 1,263 | Nov 9, 2023 |
| Nov 7, 2023 | CNMD CONMED Corp | SOpen-market sale Common Stock | -1,200 | $102.40 | $123k | 63 | Nov 9, 2023 |
| Nov 7, 2023 | CNMD CONMED Corp | MOption exercise Options To Purchase Common Stockderivative | -1,200 | $0.00 | $0 | 6,300 | Nov 9, 2023 |
Questions about Stanley W Peters III
Answered from the filings on this page, as of the latest one.
Is Stanley W Peters III buying or selling?
Not in the last 12 months. Stanley W Peters III's latest open-market trade on SEC Form 4 was sold $287k of CNMD on Jun 14, 2024.
How did Stanley W Peters III's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stanley W Peters III has 0.
Where does Stanley W Peters III file Form 4?
Stanley W Peters III has filed Form 4 at CNMD (CONMED Corp) as President AS and AET. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.